Laura Jean Flanagan
Laura Jean Flanagan's purchase track record
Laura Jean Flanagan has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/12/2023 | CALY | $60K | +11.1% | +19.0% | +15.8% |
| 11/15/2023 | CALY | $20K | +27.1% | +31.0% | +17.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
PFGC sees mixed analyst views and new institutional interest. Performance Food Group is drawing attention from new and existing investors. Billionaire Dan Loeb’s Third Point bought stakes in the company, while Morgan Stanley raised its price target to $136. Conversely, TD Cowen lowered its target to $110. The stock is currently trading near its 52-week high, reflecting a period of strong price movement.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Callaway Golf Featured in Yahoo Stock Analysis Articles. Yahoo highlighted Callaway Golf in a list of stocks under scrutiny and also compared its Q2 results to other leisure‑sector peers. The coverage shows that analysts are paying attention to the company’s recent performance and its standing among competitors.
Transaction History
| AVO | ▲ Buy | Grant | 8,240 | $0 | 4/9/2026 | View on chart |
| PFGC | ▲ Buy | Grant | 2,078 | $0 | 11/19/2025 | View on chart |
| AVO | ▲ Buy | Grant | 7,247 | $0 | 6/30/2025 | View on chart |
| CALY | ▲ Buy | Option Exercise | 8,096 | $0 | 5/29/2025 | View on chart |
| PFGC | ▲ Buy | Grant | 2,173 | $0 | 11/19/2024 | View on chart |
| CALY | ▲ Buy | Option Exercise | 6,988 | $0 | 6/6/2024 | View on chart |
| CALY | ▲ Buy | Open Market | 2,000 | $25K | 12/12/2023 | View on chart |
| CALY | ▲ Buy | Open Market | 2,775 | $35K | 12/12/2023 | View on chart |
| PFGC | ▲ Buy | Grant | 2,768 | $0 | 11/30/2023 | View on chart |
| CALY | ▲ Buy | Open Market | 1,676 | $20K | 11/15/2023 | View on chart |
| CALY | ▲ Buy | Option Exercise | 5,984 | $0 | 5/25/2023 | View on chart |
| PFGC | ▲ Buy | Grant | 2,727 | $0 | 11/16/2022 | View on chart |
| CALY | ▲ Buy | Option Exercise | 4,063 | $0 | 5/19/2022 | View on chart |
| PFGC | ▲ Buy | Grant | 3,618 | $0 | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Mission Produce (AVO) Announces 2035 Sales and EBITDA Targets
Mission Produce disclosed its 2035 strategic plan at an investor day, targeting $4 billion in sales and $450 million in EBITDA. An insider purchase of $594 k in shares was reported, indicating confidence from management. Analysts reiterated an overweight stance with a $15 price target, while some commentary notes the current valuation appears high relative to earnings.
Mission Produce (AVO) Announces 2035 Sales and EBITDA Targets. Mission Produce disclosed its 2035 strategic plan at an investor day, targeting $4 billion in sales and $450 million in EBITDA. An insider purchase of $594 k in shares was reported, indicating confidence from management. Analysts reiterated an overweight stance with a $15 price target, while some commentary notes the current valuation appears high relative to earnings.